Guo heads WSMI
This article was originally published in The Tan Sheet
Executive SummaryDihon Pharmaceuticals CEO Zhenyu Guo succeeds Christopher Combe as chairman of the World Self-Medication Industry in October 2011. In a Sept. 13 release, the federation says Guo led Dihon, based in Kunming, China, since 2003, and is executive chairman of the China Nonprescription Medicines Association. Before his private sector career, Guo headed the George Washington University's biomedical engineering laboratory. France-based WSMI is an umbrella organization for 55 OTC product member associations
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.